Showing results (1201-1210 of 1,245) with videos related to
Sort By:
Pageof 125
European Journal of Gastroenterology & Hepatology|May 21, 2009
Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosisMoon Young Kim, Soon Koo Baik, Chang Jin Yea, et al.Nature Nanotechnology|January 12, 2024
Spin coating epitaxial heterodimensional tin perovskites for light-emitting diodesHao Min, Nana Wang, Nana Chen, et al.Human Pathology|May 14, 2005
Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinomaHee Jin Chang, Kyung Hae Jung, Dae Yong Kim, et al.Journal of Gastroenterology|November 18, 2008
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat modelMoon Young Kim, Soon Koo Baik, Dong Hun Park, et al.International Immunopharmacology|October 16, 2025
Enhancing anti-tumor immunity through TIGIT blockade and tumor-directed targeting in pancreatic cancerYun Jung Um, Dongwook Kwak, Seok Yung Kim, et al.Journal of Hepatology|March 1, 2011
Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertensionMoon Young Kim, Mee Yon Cho, Soon Koo Baik, et al.International Journal of Radiation Oncology, Biology, Physics|November 14, 2006
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancerDae Yong Kim, Kyung Hae Jung, Tae Hyun Kim, et al.Cancer Research and Treatment|January 18, 2019
Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal CancerJung Ryul Oh, Boram Park, Seongdae Lee, et al.Scientific Reports|October 18, 2017
Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomasHyun Min Lee, Jae Won Joh, Se-Ri Seo, et al.Journal for Immunotherapy of Cancer|March 14, 2024
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)Ju Won Kim, Hyo Jin Lee, Ji Yoon Lee, et al.Pageof 125